Applying the concept of uncertainty to the sFlt-1/PlGF cut-offs for diagnosis and prognosis of preeclampsia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Applying the concept of uncertainty to the sFlt-1/PlGF cut-offs for diagnosis and prognosis of preeclampsia ; volume:59 ; number:7 ; year:2021 ; pages:1331-1331 ; extent:01
Clinical chemistry and laboratory medicine ; 59, Heft 7 (2021), 1331-1331 (gesamt 01)
- Urheber
-
Lévy, Pacifique
Hamdi, Safouane
Guibourdenche, Jean
Haguet, Marie Clothilde
Bailleul, Sophie
Lefèvre, Guillaume
- DOI
-
10.1515/cclm-2021-0465
- URN
-
urn:nbn:de:101:1-2022052708223608134117
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lévy, Pacifique
- Hamdi, Safouane
- Guibourdenche, Jean
- Haguet, Marie Clothilde
- Bailleul, Sophie
- Lefèvre, Guillaume
Ähnliche Objekte (12)
Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis
A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors
Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia
sFlt-1 als diagnostischer Biomarker bei pulmonaler Hypertonie
Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia
First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia
Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
sFlt-1/PIGF ratio positive associated with non-dipper type change in ambulatory blood pressure monitoring(ABPM) for preeclampsia development
Elecsys ® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
Klonierung und regulierbare Expression des löslichen VEGF-Rezeptors sFlt-1 in vitro
Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis
A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors
Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia
sFlt-1 als diagnostischer Biomarker bei pulmonaler Hypertonie
Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia
First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia
Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
sFlt-1/PIGF ratio positive associated with non-dipper type change in ambulatory blood pressure monitoring(ABPM) for preeclampsia development
Elecsys ® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
Klonierung und regulierbare Expression des löslichen VEGF-Rezeptors sFlt-1 in vitro
Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis
A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors
Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia
sFlt-1 als diagnostischer Biomarker bei pulmonaler Hypertonie
Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia
First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia
Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
sFlt-1/PIGF ratio positive associated with non-dipper type change in ambulatory blood pressure monitoring(ABPM) for preeclampsia development
Elecsys ® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?